Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3134PDF: 1124HTML: 5682 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3455PDF: 1142HTML: 2609 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3334PDF: 989HTML: 6636Untitled: 301Untitled: 259Untitled: 281Untitled: 285 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2735PDF: 937HTML: 9086Efremov 1: 288Efremov 2: 260 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4657PDF: 1859HTML: 1137 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2679PDF: 891HTML: 1768 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
5023PDF: 1651HTML: 2291Untitled: 288Untitled: 309Untitled: 330Untitled: 284Untitled: 294 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1914PDF: 1456HTML: 688 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2177PDF: 2056HTML: 813 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4272PDF: 1363HTML: 2133Table 1: 257 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2361PDF: 923HTML: 274 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7304PDF: 3878HTML: 864 -
-
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3115PDF: 1484HTML: 3749Untitled: 280Untitled: 277Untitled: 225 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2532PDF: 1959HTML: 1097 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1781PDF: 720HTML: 2459 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3079PDF: 1074HTML: 7532 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1971PDF: 2179Suppl. Files: 300HTML: 126 -
-
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1342PDF: 597HTML: 1729Figures: 223Fifures Sanz: 234tables Sanz: 236Untitled: 229 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
6027PDF: 1636HTML: 1690Untitled: 296 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1782HTML: 731PDF: 936 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2507PDF: 1065HTML: 11184 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3510PDF: 1068HTML: 3045 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
8020PDF: 2548HTML: 2184Table 1.: 290Table 2.: 312Table 3.: 275Table 4.: 281 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2627PDF: 1564HTML: 2041 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4470PDF: 2140HTML: 1981 -







